3
ICAP

Districts (or national) Bronx

october

MTN-014: Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% GelDistricts (or national):Bronx

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal ProductsDistricts (or national):Bronx

HTPN 083: Give PrEP a ShotDistricts (or national):Bronx

HVTN 704/HPTN 085: Antibody Mediated Prevention (Amp Study)Districts (or national):Bronx

HPTN 076: Phase II Safety and Acceptability of Injectible Rilpivirine for PrEPDistricts (or national):Bronx

HPTN 094: The INTEGRA StudyDistricts (or national):Bronx

CoVPN 3002: The AstraZeneca StudyDistricts (or national):Bronx

CoVPN 5002: The COMPASS StudyDistricts (or national):Bronx

IMPOWER-022: The Merck StudyDistricts (or national):Bronx

EVOGUARD/EVO100-311: The ICON StudyDistricts (or national):Bronx

ACTIV-2/A5401: The ACTIV StudyDistricts (or national):Bronx

november

MTN-014: Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% GelDistricts (or national):Bronx

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal ProductsDistricts (or national):Bronx

HTPN 083: Give PrEP a ShotDistricts (or national):Bronx

HVTN 704/HPTN 085: Antibody Mediated Prevention (Amp Study)Districts (or national):Bronx

HPTN 076: Phase II Safety and Acceptability of Injectible Rilpivirine for PrEPDistricts (or national):Bronx

HPTN 094: The INTEGRA StudyDistricts (or national):Bronx

CoVPN 3002: The AstraZeneca StudyDistricts (or national):Bronx

CoVPN 5002: The COMPASS StudyDistricts (or national):Bronx

IMPOWER-022: The Merck StudyDistricts (or national):Bronx

EVOGUARD/EVO100-311: The ICON StudyDistricts (or national):Bronx

ACTIV-2/A5401: The ACTIV StudyDistricts (or national):Bronx

december

MTN-014: Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% GelDistricts (or national):Bronx

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal ProductsDistricts (or national):Bronx

HTPN 083: Give PrEP a ShotDistricts (or national):Bronx

HVTN 704/HPTN 085: Antibody Mediated Prevention (Amp Study)Districts (or national):Bronx

HPTN 076: Phase II Safety and Acceptability of Injectible Rilpivirine for PrEPDistricts (or national):Bronx

HPTN 094: The INTEGRA StudyDistricts (or national):Bronx

CoVPN 3002: The AstraZeneca StudyDistricts (or national):Bronx

CoVPN 5002: The COMPASS StudyDistricts (or national):Bronx

IMPOWER-022: The Merck StudyDistricts (or national):Bronx

EVOGUARD/EVO100-311: The ICON StudyDistricts (or national):Bronx

ACTIV-2/A5401: The ACTIV StudyDistricts (or national):Bronx

january

MTN-014: Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% GelDistricts (or national):Bronx

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal ProductsDistricts (or national):Bronx

HTPN 083: Give PrEP a ShotDistricts (or national):Bronx

HVTN 704/HPTN 085: Antibody Mediated Prevention (Amp Study)Districts (or national):Bronx

HPTN 076: Phase II Safety and Acceptability of Injectible Rilpivirine for PrEPDistricts (or national):Bronx

HPTN 094: The INTEGRA StudyDistricts (or national):Bronx

CoVPN 3002: The AstraZeneca StudyDistricts (or national):Bronx

CoVPN 5002: The COMPASS StudyDistricts (or national):Bronx

IMPOWER-022: The Merck StudyDistricts (or national):Bronx

EVOGUARD/EVO100-311: The ICON StudyDistricts (or national):Bronx

ACTIV-2/A5401: The ACTIV StudyDistricts (or national):Bronx

february

MTN-014: Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% GelDistricts (or national):Bronx

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal ProductsDistricts (or national):Bronx

HTPN 083: Give PrEP a ShotDistricts (or national):Bronx

HVTN 704/HPTN 085: Antibody Mediated Prevention (Amp Study)Districts (or national):Bronx

HPTN 076: Phase II Safety and Acceptability of Injectible Rilpivirine for PrEPDistricts (or national):Bronx

HPTN 094: The INTEGRA StudyDistricts (or national):Bronx

CoVPN 3002: The AstraZeneca StudyDistricts (or national):Bronx

CoVPN 5002: The COMPASS StudyDistricts (or national):Bronx

IMPOWER-022: The Merck StudyDistricts (or national):Bronx

EVOGUARD/EVO100-311: The ICON StudyDistricts (or national):Bronx

ACTIV-2/A5401: The ACTIV StudyDistricts (or national):Bronx